Application of umbilical blood platelet mitochondria in preparation of drug for treating autoimmune diseases

A technology for immune diseases and platelets, which is applied to blood/immune system cells, drug combinations, allergic diseases, etc., can solve problems such as insufficient effect and large side effects, and achieve a complex storage method, small side effects, and obvious therapeutic effects. Effect

Active Publication Date: 2021-01-01
THE THIRD XIANGYA HOSPITAL OF CENT SOUTH UNIV
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The invention provides an application of umbilical cord blood platelet mitochondria in the preparation of medicines for treating autoimmune diseases, so as to overcome the deficiencies of the prior art, especially the insufficient effect and large side effects of the medicines for treating autoimmune diseases in the prior art Insufficient, providing an application of umbilical cord blood platelet mitochondria in the preparation of drugs for the treatment of autoimmune diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of umbilical blood platelet mitochondria in preparation of drug for treating autoimmune diseases
  • Application of umbilical blood platelet mitochondria in preparation of drug for treating autoimmune diseases
  • Application of umbilical blood platelet mitochondria in preparation of drug for treating autoimmune diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Preparation and Preservation of Cord Blood Platelet Mitochondria

[0040] S1. Take 20mL of cord blood and slowly add it to the lymphocyte separation medium (cord blood volume: lymphocyte separation medium volume = 1:1), centrifuge, centrifugation conditions: 20°C, 400g~1610g, 25min, start acceleration: 0, end Hourly deceleration: 0. After the centrifugation, the cord blood is stratified, and the supernatant above the peripheral blood mononuclear cell layer (PBMC) is sucked, and the action is slow and gentle, and the PBMC should not be sucked as much as possible. The start acceleration of the above centrifugation: 0, the end deceleration: 0. Only when the acceleration and deceleration are 0, can the PBMC be separated, also known as the buffy coat. If there is acceleration or deceleration, the buffy coat cells will be centrifuged to the bottom of the test tube, resulting in separation failure, and PBMC cells cannot be obtained. In this way, PBMC cells can be obtained an...

Embodiment 2

[0054] 1. Obtaining peripheral blood mononuclear cells

[0055] 1. Collect 5ml of peripheral blood in a heparin anticoagulant tube, slowly add the blood to the lymphocyte separation medium (peripheral blood volume: lymphocyte separation medium volume = 1:1), centrifuge, centrifugation conditions: 20 ° C, 400g ~ 1610g , 25min, start acceleration: 0, end deceleration: 0. After centrifugation, the cord blood is stratified, and the layer of peripheral blood mononuclear cells (PBMC for short) is sucked with a straw, and the action is slow and gentle, and as little lymphocyte fluid as possible is sucked.

[0056] 2. Continue to centrifuge the PBMC layer, centrifugation conditions: 20°C, 580g, 10min, start acceleration: +8, end deceleration: -9. Take 5ml~10ml 10× red blood cell lysate and 45ml sterilized water to prepare 1× red blood cell lysate. After the centrifugation is completed, remove the supernatant, add 1× red cracking solution for lysis for 2 minutes to 10 minutes, add 0....

Embodiment 3

[0073] 1. Isolation of donor mouse spleen cells

[0074] 1. Euthanize the donor mouse in the carbon dioxide chamber, then dislocate the neck; spray the abdomen with 70% ethanol;

[0075] 2. Make an incision at the abdomen level, peel off the skin to expose the peritoneum, use forceps to keep the peritoneum away from internal organs, and make an incision on the left abdominal peritoneum to expose and remove the spleen;

[0076] 3. Put the spleen into the serum-free culture medium (X-VIVO 15w / o Gentor Phenol Red from Lonza Company) in a 10ml petri dish, remove and discard the excess tissue in the spleen;

[0077] 4. Crush the spleen using 2 sterile glass slides to make a single cell suspension; filter the cell suspension through a 70 μm filter into a 50 ml sterile centrifuge, and rinse the filter with 5 ml of serum-free culture medium;

[0078] 5. Centrifuge the cells, centrifugation conditions: 300g, 10min, start acceleration: +8, end deceleration: -9, discard the supernatant;...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of a umbilical blood platelet mitochondria in preparation of a drug for treating autoimmune diseases. The platelet mitochondria separated from umbilical blood are used for preparing the drug for treating the autoimmune diseases. The application of the drug for treating the autoimmune diseases, which is prepared by using the umbilical blood platelet mitochondria,has the characteristics of good treatment effect, less side effect, easiness in preservation of the umbilical blood platelet mitochondria, stable function of the mitochondria and the like. Through in-vivo and in-vitro experimental tests, the result shows that the umbilical blood platelet mitochondria have obvious treatment effect on the autoimmune diseases.

Description

technical field [0001] The invention relates to the field of biopharmaceuticals, in particular to the application of umbilical cord blood platelet mitochondria in the preparation of drugs for treating autoimmune diseases. Background technique [0002] The incidence of autoimmune diseases such as inflammatory bowel disease, type 1 diabetes, systemic lupus erythematosus, and rheumatoid arthritis is increasing year by year, and has become a health problem of global concern. The cause of autoimmune diseases is still unclear, but a common feature of these diseases is the disorder of the immune system. The immune cells of the body treat their own tissues as foreign antigens, attack and damage their own tissues, and cause chronic inflammation. However, there is currently no effective cure. At present, immunosuppressive drugs and hormone therapy are often used to treat autoimmune patients, but they can only reduce symptoms and have serious long-term side effects. Therefore, there ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): A61K35/19A61P37/02C12N5/078
CPCA61K35/19A61P37/02C12N5/0644C12N2509/10
Inventor赵莲
OwnerTHE THIRD XIANGYA HOSPITAL OF CENT SOUTH UNIV